M Lab™ Podcasts

It’s been said that “competition makes us faster, but collaboration makes us better!” And while the author of this quote may still be unknown, the message that it inspires is intensely familiar. The M Lab™ Collaboration Centers from MilliporeSigma are fundamental to the development of innovative resolutions to common bioproduction problems. The technical expertise of the M Lab™ Collaboration Centers spans all aspects of the bioprocessing spectrum, and the facilities are located in key biopharma hubs around the world—with experts able to tackle region-specific challenges, as well as the toughest scientific problems. In the podcasts below, you can listen to compelling stories of novel solutions and innovative application of technologies that brought M Lab™ Collaboration Centers team members together with various biopharmacuetical manufacturers to make science, better.

Podcast Series: Collaborations in Bioprocessing

Viral epidemic or pandemic spreading around the world concept with microscopic virus cells and the world map. Healthcare, medical, global contagion and communicable disease 3d rendering illustration.

Emerging Markets Collaborate to Succeed in Post-Pandemic World

Biopharma industry collaborations are on the rise as researchers seek novel ways to combat post-pandemic diseases. Collaboration can take many forms and offer numerous benefits, including access to new technologies, expertise, and funding, as well as the ability to share risks and responsibilities. Successful collaborations can lead to the development of new treatments for patients, while simultaneously reducing costs and time for manufacturers.

Science technology concept. Scientific examination. Scientist.

Improving Protein Therapeutic Production is a Key Goal of Biopharma 4.0

In this GENcast, sponsored by MilliporeSigma, we chatted with two team members and picked their brains about some of the challenges currently facing manufacturers in this space. Listen in and hear what they have to say.

Scientists examining and discussing DNA double helix diagram

Biomanufacturing’s 10-Year Plan for the Future

Navigating the Regulatory Terrain during Cell & Gene Therapy Production

Solve Your Biotherapeutic Challenges with Help from Gene Therapy University

In this podcast we sat down with two team members to tell us more about the difficulties often faced by scientists in the cell and gene therapy space and how they help clients traverse the challenging production landscape.

Engineered Therapy: Ramping Up CAR-T Biomanufacturing Goals

In this GENcast, where our panelists discuss the expansion of CAR-T operations at the Brazilian Hematology Center and how the M Lab team was able to rapidly get production pipelines flowing so patients could receive the treatments they needed.

Black scientist working with scientific images

Collaborating for Filtration Success, Virtually

Bioproduction work is never easy but trying to run filter sizing trials in the midst of a global pandemic only serves to make matters even more difficult. So, when scientists at Janssen Sciences Ireland found themselves between the proverbial rock and a hard place due to COVID-19 travel restrictions, they...